To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

InSite Vision Inc.

(INSV)

Hambrecht & Quist analyst Alex Zisson initiated coverage with a "buy," saying the

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE